ESSA PHARMA INC's ticker is EPIX and the CUSIP is 29668H708. A total of 76 filers reported holding ESSA PHARMA INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23,722 | +288.6% | 7,677 | +239.5% | 0.00% | – |
| Q2 2023 | $6,105 | -9.1% | 2,261 | 0.0% | 0.00% | – |
| Q1 2023 | $6,715 | -98.7% | 2,261 | -97.3% | 0.00% | – |
| Q1 2022 | $525,000 | -56.9% | 85,069 | -0.7% | 0.00% | – |
| Q4 2021 | $1,217,000 | +86.4% | 85,638 | +4.9% | 0.00% | – |
| Q3 2021 | $653,000 | -65.6% | 81,638 | +23.0% | 0.00% | – |
| Q2 2021 | $1,897,000 | +4115.6% | 66,387 | +1668.0% | 0.00% | – |
| Q4 2020 | $45,000 | +73.1% | 3,755 | 0.0% | 0.00% | – |
| Q3 2020 | $26,000 | +100.0% | 3,755 | +76.7% | 0.00% | – |
| Q2 2020 | $13,000 | – | 2,125 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Soleus Capital Management, L.P. | 4,145,117 | $12,310,997 | 1.28% |
| BVF INC/IL | 8,748,629 | $25,983,428 | 0.95% |
| Ally Bridge Group (NY) LLC | 236,583 | $702,652 | 0.92% |
| PFM Health Sciences, LP | 4,161,461 | $12,359,539 | 0.55% |
| Bellevue Group AG | 7,898,583 | $23,458,792 | 0.34% |
| Rhenman & Partners Asset Management AB | 356,500 | $1,051,675 | 0.12% |
| Orbimed Advisors | 1,198,337 | $3,559,061 | 0.07% |
| Privium Fund Management (UK) Ltd | 20,032 | $61,498 | 0.05% |
| Rock Springs Capital Management LP | 524,944 | $1,559,084 | 0.04% |
| Hunting Hill Global Capital, LLC | 10,000 | $29,700 | 0.02% |